Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Michael Chin | $1 Million Boost to Pediatric Cancer Research

Michael Chin details the recent news that The Damon Runyon Cancer Research Foundation has named four exceptional researchers as beneficiaries of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, submitting about $1 million to address a basic lack of subsidizing for pediatric disease research.

  • Identifiez-vous pour voir les commentaires

  • Soyez le premier à aimer ceci

Michael Chin | $1 Million Boost to Pediatric Cancer Research

  1. 1. $ 1 MILLION BOOST TO PEDIA TRIC CA NCER RESEA RCH Everything You Need To Know About the New B Y M I C H A E L C H I N
  2. 2. A NEW GROUP OF LEA DERS Pediatric cancer research just scored a big win. In July, four young pediatric cancer researchers were awarded $ 1 million in fellowship money to pursue innovative treatments for an area of cancer that' s largely underfunded.
  3. 3. DEFINING THE NEED Since cancer happens less much of the time in youngsters and teens than in grown- ups, pediatric cancer research does not get noteworthy financing from either the National Cancer Institute or the biopharmaceutical business. Of course, this then means that are fewer advances and fewer researchers in this field.
  4. 4. BUT SOME INSTITUTIONS A RE STEPPING IN TO CHA NGE THINGS
  5. 5. The Damon Runyon Cancer Research Foundation and Sohn Conference Foundations combined efforts to award four outstanding young scientists as recipients of the prestigious Damon Runyon- Sohn Pediatric Cancer Research Fellowship, The fellows represent some of the best and brightest minds in the medical field who will take an intrepid approach to tackling cancers in children and young adults.
  6. 6. MEET THE FELLOWS Challice L. Bonifant, MD, PhD 1 2 3 3 4 Dr. Bonifant will study how best to direct the immune system to combat acute myeloid leukemia ( AML) , a blood cancer of both children and adult. The goal: Develop new strategies to treat AML. Michael A. Koldobskiy, MD, PhD Dr. Koldobskiy will study the ways that cancer cells rely on chemical marks that modify the expression of genes. The goal: Identify new targets for treatment of pediatric acute lymphoblastic leukemia, Tamara P. Miller, MD Dr. Miller will study the toxicities of cancer treatment and improving how the side effects of leukemia treatment are reported. The goal: Define the true rates of toxicities of leukemia therapy Cara A. Rabik, MD, PhD Dr. Rabik will study how mutations in the WT1 gene result in methylation changes in acute myeloid leukemia. The goal: Evaluate if certain drugs can efficiently treat this particular mutation.
  7. 7. With the hard work and insight of these four doctors--and many others--we'll continue making strides in this particularly underserved area of research.
  8. 8. michaelchinworcester.org @MichaelChin_ A PRESENTA TION BY MICHA EL CHIN Source: DAMON RUNYON CANCER RESEARCH FOUNDATION. "Four Young Pediatric Cancer Research Fellows Earn $1 Million in New Awards."EurekAlert!, 21 July 2016. Web. 18 Aug. 2016.

×